secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aptose Biosciences Inc. (APTOF)
CIK:        0000882361
Form:       8-K
Filed at:   2026-03-23T23:59:59+00:00
Accession:  0001171843-26-001837
Event type: m_and_a
Sentiment:  positive
Materiality: 0.62
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Glass Lewis backs Aptose's plan for Hanmi acquisition; vote deadline March 27
-----------------------------------------------------------------------------

- Glass Lewis recommends shareholders vote FOR the arrangement with Hanmi and the continuance to ABCA.
- Proxy voting deadline is 11:00 a.m. EST on Friday, March 27, 2026.
- Special meeting reconvened for March 31, 2026, after SEC comments on the transaction statement.
- Board and Special Transaction Committee unanimously recommend voting FOR the arrangement.
- Deal is subject to court approval and TSX approval; Sodali & Co assisting with proxy solicitation.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/882361/000117184326001837/0001171843-26-001837-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/882361/000117184326001837/f8k_032326.htm
  HTML page:      https://secwatch.observer/filing/0001171843-26-001837

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer